Rising Clinical Negligence Costs: Focusing on Standards, Not Silencing Patients

The Department of Health and Social Care’s recent acceptance of the Public Accounts Committee’s recommendation to develop an operational plan by Autumn 2026 to address rising clinical negligence costs deserves close scrutiny.

Clinical negligence payments have increased dramatically – from around £0.6bn in 2006/07 to £3.1bn in 2024/25. These figures are often presented as a problem in their own right. But focusing on cost alone risks missing a more fundamental issue.

This is not primarily a claims problem. It is a patient safety and standards problem.

Behind the figures are real people

Clinical negligence costs are often framed as a drain on NHS resources, but that narrative risks oversimplifying a complex system failure. Behind every claim statistic is a patient who has suffered avoidable harm, often with life‑changing or life‑limiting consequences, and a health service struggling with workforce pressures, systemic underinvestment, and growing clinical complexity.

Rising costs do not occur in isolation; they reflect repeated failures to prevent avoidable harm, delays in acknowledging mistakes, and missed opportunities to learn from serious incidents.

For many claimants, litigation is not about “compensation culture” or opportunism. It is about:

Any reform that loses sight of that reality risks further eroding public trust in the healthcare system.

Cost is a symptom – not the root cause

Rising compensation and legal costs do not exist in a vacuum. They reflect:

If reform focuses solely on limiting damages or restricting access to justice, it risks treating the symptom rather than the disease.

True cost control must start earlier – with preventing harm, not merely managing claims after the fact.

Reducing compensation or restricting access to justice would do nothing to tackle these underlying issues. In fact, it risks masking harm rather than preventing it.

Reform must not undermine patient rights

The government has confirmed a commitment to reform, but with few details at this stage, there is understandable concern about what that reform may involve.

Any changes must carefully avoid:

A system that is genuinely committed to reducing litigation costs should prioritise early accountability, transparency, and learning, not procedural hurdles.

Learning from harm is the only sustainable solution

If the aim is long‑term cost reduction, the most effective route is well known:

Where harm is prevented, claims do not arise. Where mistakes are acknowledged early, cases resolve more quickly and at substantially lower cost. Where lessons are embedded, the same errors are less likely to recur.

This is not radical thinking – it is common sense.

Waiting until 2026: a risk and an opportunity

An operational plan by Autumn 2026 may feel frustratingly distant for those already affected by substandard care. However, if used properly, this period could allow for meaningful, evidence‑based reform that strengthens – rather than weakens – patient protection.

Reform must start from a clear principle:

If the forthcoming plan places patient safety, standards, and accountability at its core, it could represent a step forward. If it focuses solely on reducing payouts, it risks compounding the very problems it seeks to solve.

Clinical negligence costs tell a story. The challenge for government is to decide whether it wants to address the cause – or simply bury the evidence.